Companies in the therapeutics sector developing innovative solutions and technologies.
Explore 1,733 recently funded therapeutics companies with verified founder contact information and fundraising data.
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.
Anagram Therapeutics develops orally delivered enzyme therapies for malabsorption syndromes and nutrient deficiencies.
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.
Autoimmunity BioSolutions develops a future immuno-corrective treatment that restores healthy immune function.
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Abivax develops medicines that alter the body's natural immune system mechanisms.
IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.
CELYSTRA Pharma identifies, licenses, and commercializes innovative therapies for rare and underserved diseases in Canada.
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.
Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.
Illumina Radiopharmaceuticals
CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.
Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.
Tacalyx is a biotech company that develops therapies that target cancer by focusing on tumor-associated carbohydrate antigens.
Axoft is a revolutionary seamless interface between brain and machine.
AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.
Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.
Cancentus is a cancer treatment company that provides AI-based disease discovery solutions.
The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 1,733 therapeutics companies tracked in the VCBacked database.
Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked